tetano
Editor, Senior Moderator
World J Pediatr
. 2020 Sep 28;1-9.
doi: 10.1007/s12519-020-00393-x. Online ahead of print.
SARS-CoV-2 infection in children requiring hospitalization: the experience of Navarra, Spain
Laura Moreno-Galarraga[SUP] 1 2 3 [/SUP], Mar?a Urretavizcaya-Mart?nez[SUP] 4 [/SUP], Josune Alegr?a Echauri[SUP] 5 [/SUP], Marcos Garc?a Howard[SUP] 4 [/SUP], Eva Ruperez Garc?a[SUP] 4 [/SUP], Sergio Aguilera-Albesa[SUP] 6 7 [/SUP], Valent?n Alzina de Aguilar[SUP] 8 9 [/SUP], Mercedes Herranz Aguirre[SUP] 6 4 [/SUP]
Affiliations
Abstract
Background: Coronavirus disease 2019 in children, or pediatric COVID-19, initially was described as an acute respiratory syndrome similar to the adult presentation but with less severe manifestations.
Methods: We describe the clinical characteristics, disease presentation, treatments and outcomes of all pediatric cases with COVID-19 admitted to the reference hospitals in Navarra, Spain during the first wave of the COVID-19 outbreak (February-May 2020).
Results: We found a low number of hospitalized cases in infants and children compared to adults with a hospitalization ratio of 1:180. Most of these hospitalized cases did not suffer from severe disease. Over 80% of infections reported household contacts, and the mother was the known-contact in 83% of these cases. 72% of hospitalized cases were previously healthy children. We describe how symptoms in pediatric cases are nonspecific and how COVID-19 can be presented with a wide range and variety of symptoms. Respiratory symptoms are not always present, and severe neurological and cardiac features can occur in previously healthy children.
Conclusion: Epidemiological description and case reports will be key to a better recognition and to adequate treatment of pediatric patients with COVID-19.
Keywords: Coronavirus disease 2019; Hospitalization; Severe acute respiratory syndrome coronavirus 2.
. 2020 Sep 28;1-9.
doi: 10.1007/s12519-020-00393-x. Online ahead of print.
SARS-CoV-2 infection in children requiring hospitalization: the experience of Navarra, Spain
Laura Moreno-Galarraga[SUP] 1 2 3 [/SUP], Mar?a Urretavizcaya-Mart?nez[SUP] 4 [/SUP], Josune Alegr?a Echauri[SUP] 5 [/SUP], Marcos Garc?a Howard[SUP] 4 [/SUP], Eva Ruperez Garc?a[SUP] 4 [/SUP], Sergio Aguilera-Albesa[SUP] 6 7 [/SUP], Valent?n Alzina de Aguilar[SUP] 8 9 [/SUP], Mercedes Herranz Aguirre[SUP] 6 4 [/SUP]
Affiliations
- PMID: 32989666
- PMCID: PMC7521568
- DOI: 10.1007/s12519-020-00393-x
Abstract
Background: Coronavirus disease 2019 in children, or pediatric COVID-19, initially was described as an acute respiratory syndrome similar to the adult presentation but with less severe manifestations.
Methods: We describe the clinical characteristics, disease presentation, treatments and outcomes of all pediatric cases with COVID-19 admitted to the reference hospitals in Navarra, Spain during the first wave of the COVID-19 outbreak (February-May 2020).
Results: We found a low number of hospitalized cases in infants and children compared to adults with a hospitalization ratio of 1:180. Most of these hospitalized cases did not suffer from severe disease. Over 80% of infections reported household contacts, and the mother was the known-contact in 83% of these cases. 72% of hospitalized cases were previously healthy children. We describe how symptoms in pediatric cases are nonspecific and how COVID-19 can be presented with a wide range and variety of symptoms. Respiratory symptoms are not always present, and severe neurological and cardiac features can occur in previously healthy children.
Conclusion: Epidemiological description and case reports will be key to a better recognition and to adequate treatment of pediatric patients with COVID-19.
Keywords: Coronavirus disease 2019; Hospitalization; Severe acute respiratory syndrome coronavirus 2.